4 Results for "

aPKC-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "aPKC-IN-1" in MCE Product Catalog:

Cat. No.: HY-131220
CAS No.: 15854-12-3
Target:  

PKC

Research Areas:  

Inflammation/Immunology

aPKC-IN-1 (compound 1) is an atypical protein kinase C (aPKCζ) inhibitor. aPKC-IN-1 can be used for the study of a host of diseases involving increased vascular permeability and inflammation [1].
loading...
    loading...
Cat. No.: HY-W030338
CAS No.: 15854-08-7
Target:  

Endogenous Metabolite

Research Areas:  

Inflammation/Immunology

aPKC-IN-2 is a small molecule inhibitor that inhibits aPKC activity. aPKC-IN-2 can effectively block vascular endothelial permeability in cell culture and in vivo experiments. aPKC-IN-2 shows biological activity in interfering with NFκB-driven gene transcription and is associated with inflammatory responses. aPKC-IN-2 has a significant inhibitory effect on vascular endothelial permeability induced by VEGF and TNF, and its EC50 value is in the low nanomolar range. The structural characteristics of aPKC-IN-2 reveal key elements of its inhibitory activity, providing the possibility for further development of small molecule aPKC inhibitors .
loading...
    loading...
Cat. No.: HY-167114
CAS No.: 2143100-98-3
Target:  

Aurora Kinase PKC

Research Areas:  

Cancer

(Rac)-Aurora A/PKC-IN-1 (Compund 2e) is an orally active Aurora A and PKC (α, β1, β2 and θ) kinase inhibitor. (Rac)-Aurora A/PKC-IN-1 has antiproliferative activity in breast cancer cells in vitro and antimetastatic activity in vivo [1].
loading...
    loading...
Cat. No.: HY-144307
CAS No.: 3031505-76-4
Target:  

Aurora Kinase PKC

Research Areas:  

Cancer

Aurora A/PKC-IN-1 (Compound 2e) is a potent dual inhibitor of Aurora A (AurA) and PKC (α, β1, β2, and θ) kinases with IC50s of 6.9 nM and 16.9 nM for AurA and PKCα, respectively. Aurora A/PKC-IN-1 has antiproliferative activity in breast cancer cells and antimetastatic activity [1].
loading...
    loading...